Abstract #3820
Evaluation of metronomic chemotherapy in a mouse model using DCE-MRI and DWI
Melanie Freed 1,2 , Kerryanne Winters 1,2 , Jin Zhang 1,2 , and Sungheon G. Kim 1,2
1
Center for Advanced Imaging Innovation and
Research (CAI2R), Dept. Radiology, NYU School of
Medicine, New York, NY, United States,
2
Bernard
and Irene Schwartz Center for Biomedical Imaging, Dept.
Radiology, NYU School of Medicine, New York, NY, United
States
Metronomic chemotherapy is a promising method that
delivers chemotherapy in low, frequent doses and has
been shown to demonstrate superior response over
traditional chemotherapy in some cases. There is a need
to develop mouse models and techniques for evaluating
dose and scheduling of metronomic chemotherapy to
optimize its usage and benefits. In this study, we
investigate the use of DCE-MRI and DWI to evaluate
metronomic chemotherapy of BALB/c mice with implanted
4T1 mouse mammary tumor cells. Our data suggests this
may be a good model for advanced breast cancer and that
ADC values may be sensitive to early therapy response.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
